drugset / Trial / NCT02777437
Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer
Phase 2/3
Unknown
1960 enrolled
Fudan University
Shanghai Jiao Tong University School of Medicine · collabTongji University · collabZhejiang University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Primary Outcome Measures: Disease free survival Secondary Outcome Measures: Overall survival Adverse events (Mortality, morbidity) The proportion of completion of Laparoscopic Surgery Estimated Enrollment: Oct, 2016 Study Start Date: Oct, 2016 Estimated Study Completion Date: Oct, 2019 Estimated Primary Completion Date: Oct, 2021 Groups/Cohorts 1. Laparoscopic surgery for T4 colon cancers 2. Neoadjuvantive chemotherapy + Laparoscopic surgery for T4 colon cancers
Timeline
- Start
- 2016-10
- Primary completion
- 2019-10
- Completion
- 2021-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | — |
| Subject | OXA | Unknown | — | — |
| Subject | fluorouracil | Small molecule | — | — |